We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advancing Drug Discovery Through Academic–Industry Collaboration

Article   Nov 30, 2017 | by Laura Elizabeth Mason, Science Editor, Technology Networks

 
Advancing Drug Discovery Through Academic–Industry Collaboration
 
 
 

RELATED ARTICLES

Standardization Challenges in Pharmaceutical Product Labeling

Article

Product labels can be viewed as a “clinical instruction manual”, providing a concise description of the benefits and risks for a consumer and relevant information to dispensers, patients, and their caregivers. Here we take a look at labeling compliance, the importance of keeping information up-to-date, and risks associated with noncompliance.

READ MORE

Francis Mojica: The Modest Microbiologist Who Discovered and Named CRISPR

Article

Kicking off Technology Networks Explores the CRISPR Revolution, Professor Mojica, or "Francis", takes us on a journey back to the original research that, despite being deemed "crazy" by members of the scientific community at the time, led to the CRISPR revolution that is anticipated to edit evolution forever.

READ MORE

Who Is Responsible for Reproducible Science?

Article

Reproducibility is now recognized as a core feature of good scientific practice but too many papers fail to meet the grade. We talked to Leslie D McIntosh, CEO of Ripeta, on the topic of reproducibility. In this interview, we ask Leslie about the concepts within Ripeta’s recent report on the state of reproducible science in 2019.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE